{"id":"CHEMBL104264","canonicalSmiles":"O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12","inchiKey":"ZKZXNDJNWUTGDK-NSCUHMNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"H-89","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["H-89"],"crossReferences":{"PubChem":["26755654","26755655","50110953"],"drugbank":["DB07995"]},"childChemblIds":["CHEMBL1315166"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1078549","canonicalSmiles":"C[C@@]12C[C@@]3(O)O[C@@H](O1)[C@]1(COC(=O)c4ccccc4)[C@@H]3C[C@@]21O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"YKRGDOXKVOZESV-QYDSDWLYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAEONIFLORIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-178886","Paeoniflorin","Peoniflorin"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1080759","canonicalSmiles":"COc1cc2c(cc1C(N)=O)CC[C@@H]1[C@@H]2CC[C@]2(C)C=CC[C@@H]12","inchiKey":"YQJWOUQGXATDAE-ACNBBOPNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1080759","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB05959"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1094966","canonicalSmiles":"CC(C)(C)NCC(O)c1ccc(O)c(CO)n1","inchiKey":"VQDBNKDJNJQRDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRBUTEROL","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ARA-211","Pirbuterol"],"crossReferences":{"Wikipedia":["Pirbuterol"],"drugbank":["DB01291"],"chEBI":["8245"]},"childChemblIds":["CHEMBL1997417","CHEMBL3989646","CHEMBL1200444"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["HP_0006536","MONDO_0004979"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for asthma and airway obstruction."}
{"id":"CHEMBL1096885","canonicalSmiles":"CCCCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O","inchiKey":"ZOCKGBMQLCSHFP-KQRAQHLDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALRUBICIN","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Valstar","Valstar preservative free"],"synonyms":["AD 32","AD-32","NSC-246131","Valrubicin"],"crossReferences":{"PubChem":["144205810"],"Wikipedia":["Valrubicin"],"drugbank":["DB00385"]},"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0008528","EFO_0006544","EFO_0000313","MONDO_0004647","MONDO_0001187"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for carcinoma and neoplasm and has 3 investigational indications."}
{"id":"CHEMBL1171433","canonicalSmiles":"O=S(=O)(O)Cc1ccccc1","inchiKey":"NIXKBAZVOQAHGC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLMETHANESULFONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenylmethanesulfonic Acid"],"crossReferences":{"drugbank":["DB03297"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1187694","canonicalSmiles":"OC(c1ccccc1)(c1ccccc1)C1CN2CCC1CC2","inchiKey":"PZMAHNDJABQWGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUIFENADINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quifenadine"],"crossReferences":{"PubChem":["144205405","29216174"],"drugbank":["DB13713"]},"childChemblIds":["CHEMBL1510616","CHEMBL515462"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1196","canonicalSmiles":"CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N","inchiKey":"KCLANYCVBBTKTO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPARACAINE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Alcaine","Kainair","Ophthaine","Ophthetic","Paracaine","Proparacaine","Proxymetacaine"],"crossReferences":{"DailyMed":["proparacaine%20hydrochloride"],"PubChem":["11112907","124882712","174006303"],"Wikipedia":["Proxymetacaine"],"drugbank":["DB00807"],"chEBI":["8485"]},"childChemblIds":["CHEMBL1200464"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["HP_0009926","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953 and has 1 investigational indication."}
{"id":"CHEMBL1200688","canonicalSmiles":"CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C","inchiKey":"NSYZCCDSJNWWJL-YXOIYICCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERYTHROMYCIN ETHYLSUCCINATE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arpimycin","E-mycin","E-mycin e","E.e.s.","E.e.s. 200","E.e.s. 400","Erymin","Eryped","Erythroden","Erythromycin ethylsuccinate","Erythroped","Erythroped a","Erythroped fte","Erythroped fte sf","Erythroped pi","Erythroped pi sf","Erythroped sf","Pediamycin","Pediamycin 400","Primacine","Rommix 125","Wyamycin","Wyamycin e"],"synonyms":["Erythromycin ethyl succinate","Erythromycin ethylsuccinate","NSC-756758","Sterile erythromycin ethylsuccinate"],"crossReferences":{"DailyMed":["erythromycin%20ethylsuccinate"],"PubChem":["144207046","46500619","49648467","855551"],"TG-GATEs":["82"],"chEBI":["31555"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL1200770","canonicalSmiles":"CC(=O)N(CC(C)C(=O)O)c1c(I)cc(I)c(N)c1I","inchiKey":"GSVQIUGOUKJHRC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOCETAMIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cholebrine"],"synonyms":["Iocetamic acid","MP-620"],"crossReferences":{"PubChem":["144204131","56463701"],"Wikipedia":["Iocetamic_acid"],"drugbank":["DB09403"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1200814","canonicalSmiles":"CC(=O)Nc1nnc(S([NH-])(=O)=O)s1.[Na+]","inchiKey":"MRSXAJAOWWFZJJ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETAZOLAMIDE SODIUM","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL20","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acetazolamide sodium","Diamox"],"synonyms":["Acetazolamide Sodium","Acetazolamide sodium","Acetazolamide sodium salt","Sodium acetazolamide","Vetamox"],"crossReferences":{"chEBI":["31163"]},"linkedTargets":{"rows":["ENSG00000167434","ENSG00000133742","ENSG00000104267","ENSG00000074410"],"count":4},"linkedDiseases":{"rows":["MONDO_0001744","EFO_0009373","HP_0001250","EFO_0000516"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and has 4 approved indications."}
{"id":"CHEMBL1201222","canonicalSmiles":"C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN","inchiKey":"VOBHXZCDAVEXEY-JSGCOSHPSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LISDEXAMFETAMINE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["L-lysine-dextroamphetamine","Lisdexamfetamine","Lisdexamphetamine"],"crossReferences":{"DailyMed":["lisdexamfetamine%20dimesylate"],"Wikipedia":["Lisdexamfetamine"],"drugbank":["DB01255"]},"childChemblIds":["CHEMBL1201178"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319","ENSG00000165646"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","MONDO_0005090","EFO_0005203","EFO_0005204","EFO_0002610","MONDO_0002009","EFO_0001073","EFO_0004698","EFO_0005924","HP_0100543","EFO_0003890","MONDO_0002050","EFO_0000289","MONDO_0005301","MONDO_0002277","EFO_0004701","EFO_0000516","EFO_0003922"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 5 approved and 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201361","canonicalSmiles":"C[C@@H]1C[C@H]2[C@H]3[C@H]([C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO)[C@@]1(C)C=CC(=O)C=C1C[C@H]3Cl","inchiKey":"FJXOGVLKCZQRDN-PHCHRAKRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALCLOMETASONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Alclometasone"],"drugbank":["DB00240"],"chEBI":["53776"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1208302","canonicalSmiles":"CCCCCCCCCCS(=O)(=O)O","inchiKey":"KVGOXGQSTGQXDD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1208302","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06893"]},"childChemblIds":["CHEMBL538615"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1208829","canonicalSmiles":"COc1c(NC(=O)C(=O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O","inchiKey":"UUROSJLZNDSXRF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ITX-5061","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124360067"]},"childChemblIds":["CHEMBL3402567"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL121","canonicalSmiles":"CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1","inchiKey":"YASAKCUCGLMORW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ROSIGLITAZONE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"classes":["Cardiotoxicity"],"year":2010},"tradeNames":["Avandia"],"synonyms":["Avandamet","Avandaryl","Avandia","BRL-49653","Gaudil","NSC-758698","Rezult","Rosiglitazone","Rosiglizole","Rosvel","TDZ-01"],"crossReferences":{"DailyMed":["rosiglitazone%20maleate"],"PubChem":["144204987","170465417","174007204","26748954"],"Wikipedia":["Rosiglitazone"],"drugbank":["DB00412"],"chEBI":["50122"]},"childChemblIds":["CHEMBL843","CHEMBL1704605"],"linkedTargets":{"rows":["ENSG00000132170"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","MONDO_0005090","HP_0002745","EFO_0003095","EFO_0007444","EFO_0001065","EFO_0004234","EFO_1001249","MONDO_0007254","EFO_0000373","EFO_1001110","EFO_0003914","EFO_1000783","HP_0100543","EFO_0000673","EFO_0004272","EFO_0003047","EFO_1000785","EFO_0000400","EFO_0002546","EFO_1000158","EFO_0000616","HP_0001952","EFO_0000685","EFO_0006859","HP_0003124","EFO_0006911","EFO_0001645","EFO_0004236","EFO_0000660","Orphanet_309005","EFO_0000311","EFO_0000537","EFO_0000195","EFO_0000589","EFO_0001068","EFO_1001121","EFO_0002614","EFO_0000764","MONDO_0005147","MONDO_0004975","MONDO_0004979","EFO_1001051","EFO_1001373","MONDO_0005148","EFO_0000691","EFO_0003767"],"count":47},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for type 2 diabetes mellitus and diabetes mellitus and has 43 investigational indications. It was withdrawn in European Union  in 2010 due to Cardiotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1229585","canonicalSmiles":"CCCCOc1cc(C[C@@H]2CNC(=O)N2)ccc1OC","inchiKey":"PDMUULPVBYQBBK-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229585","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11113488"],"drugbank":["DB06842"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230191","canonicalSmiles":"O=P(O)(O)OP(=O)(O)OP(=O)(O)O","inchiKey":"UNXRWKVEANCORM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIPHOSPHATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Triphosphate"],"crossReferences":{"drugbank":["DB03896"],"chEBI":["39949"]},"childChemblIds":["CHEMBL3183517"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1231358","canonicalSmiles":"Cc1ccc2c(c1)C(=O)[C@]1(O)CCN(c3ccccc3)C1=N2","inchiKey":"LZAXPYOBKSJSEX-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231358","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26753178","29215123"],"drugbank":["DB01944"],"chEBI":["75388"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231453","canonicalSmiles":"Oc1ccc(C2(c3ccc(O)cc3)CCCCC2)cc1","inchiKey":"SDDLEVPIDBLVHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231453","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208215"],"drugbank":["DB07485"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233882","canonicalSmiles":"CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21","inchiKey":"GEZALMMCQYDFML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233882","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08054"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234086","canonicalSmiles":"CNS(=O)(=O)Cc1ccc(N/N=C2\\C(=O)Nc3ccc4ncsc4c32)cc1","inchiKey":"GEWPSTLKJDIUHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234086","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08123"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234585","canonicalSmiles":"O=C(Nc1ccc(Cl)cc1)c1cc2ccccc2cc1OP(=O)(O)O","inchiKey":"RQAQWBFHPMSXKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234585","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08240"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234916","canonicalSmiles":"CC(=O)OC[C@H](N)C(=O)O","inchiKey":"VZXPDPZARILFQX-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234916","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01837"],"chEBI":["17981"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236441","canonicalSmiles":"CC(=O)n1c2c(c3ccccc31)CCCC2=O","inchiKey":"MIGJEXKBUJPKJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236441","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08655"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1330596","canonicalSmiles":"CC(N)(Cc1ccc(O)cc1)C(=O)O","inchiKey":"NHTGHBARYWONDQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RACEMETYROSINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.-methyl-p-tyrosine","Alpha-methyl-p-tyrosine","D,l-metyrosine","Dl-2-methyl-p-tyrosine","Dl-metyrosine","Racemetirosine","Racemetyrosine","SM-88","SM-88 COMPONENT RACEMETYROSINE"],"crossReferences":{"PubChem":["50105713","90340781"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL135302","canonicalSmiles":"NC(=O)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"UKWLGCFJAVEFPE-DVKNGEFBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL135302","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02720"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL135400","canonicalSmiles":"CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1","inchiKey":"GBBSUAFBMRNDJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOPICLONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zileze 3.75","Zileze 7.5","Zimovane","Zimovane ls"],"synonyms":["Amoban","Imovane","NSC-758463","RP 27267","RP-27267","Zopiclone"],"crossReferences":{"PubChem":["124881861","26747152","866104"],"Wikipedia":["Zopiclone"],"drugbank":["DB01198"],"chEBI":["32315"]},"linkedTargets":{"rows":["ENSG00000022355","ENSG00000109158","ENSG00000145863","ENSG00000011677","ENSG00000151834","ENSG00000145864","ENSG00000186297","ENSG00000166206","ENSG00000163288"],"count":9},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002050","MONDO_0002009","EFO_0004329","HP_0000726","EFO_0005230","EFO_0004698","EFO_0003918"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL136737","canonicalSmiles":"Cc1ncc(CNC(=O)N(CCCl)N=O)c(N)n1","inchiKey":"VFEDRRNHLBGPNN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIMUSTINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-758675","Nimustine","Nimustine hydrochloride"],"crossReferences":{"PubChem":["11111557","144203765","170466029","50106657","85231161","90341805"],"drugbank":["DB13069"],"chEBI":["75270"]},"childChemblIds":["CHEMBL1256616"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1477036","canonicalSmiles":"CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)O","inchiKey":"HNSDLXPSAYFUHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOCUSATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Diocto","Docusate","Docusates","Spolion 8"],"crossReferences":{"PubChem":["104171408","29216456"],"Wikipedia":["Dioctyl_sodium_sulfosuccinate"],"drugbank":["DB11089"],"chEBI":["534"]},"childChemblIds":["CHEMBL1905872","CHEMBL2107648","CHEMBL2106608"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL1506","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1","inchiKey":"PXKHGMGELZGJQE-ILBGXUMGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORAMPHENICOL PALMITATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chlorolifarina","Chloromycetin palmitate","Chloropal"],"synonyms":["Chlorambon","Chloramphenicol Palmitate","Chloramphenicol palmitate","Chloramphenicoli palmitas","Clorolifarina","Detreopal","NSC-756675"],"crossReferences":{"PubChem":["144206645"],"drugbank":["DB14658"],"chEBI":["3605"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 3 approved indications."}
{"id":"CHEMBL1531","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3C(=C)C[C@@]21CC","inchiKey":"GCKFUYQCUCGESZ-BPIQYHPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETONOGESTREL","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Implanon","Nexplanon"],"synonyms":["Etonogestrel","Implanon","ORG 3236","ORG-3236"],"crossReferences":{"DailyMed":["etonogestrel"],"PubChem":["144206191","50113279"],"Wikipedia":["Etonogestrel"],"drugbank":["DB00294"],"chEBI":["50777"]},"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["MP_0001845","EFO_0000765","Orphanet_232","EFO_0001065","EFO_0000764","EFO_0000180","HP_0100607","EFO_0003932","EFO_0000284","EFO_0000660"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 4 investigational indications."}
{"id":"CHEMBL1578","canonicalSmiles":"CCCC(CCC)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]2(C)C.[Br-]","inchiKey":"QSFKGMJOKUZAJM-CNKDKAJDSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ANISOTROPINE METHYLBROMIDE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1186610","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anisotropine methylbromide","Valpin","Valpin 50"],"synonyms":["Anisotropine methylbromide","Methyloctatropine bromide","Octatropine methylbromide","Octatropone bromide","Octotropine methylbromide"],"crossReferences":{"PubChem":["144204422","144207024","56422429","855548"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL1584","canonicalSmiles":"CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2","inchiKey":"BTFMCMVEUCGQDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERACETAZINE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Quide"],"synonyms":["NSC-760067","PC-1421","Piperacetazine"],"crossReferences":{"PubChem":["11112549","144204091","170465363","56463171"],"Wikipedia":["Piperacetazine"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1969."}
{"id":"CHEMBL160519","canonicalSmiles":"CCC(NC(C)C)C(O)c1ccc(O)c2[nH]c(=O)ccc12","inchiKey":"FKNXQNWAXFXVNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROCATEROL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Meptin","Procaterol"],"childChemblIds":["CHEMBL1322218"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["HP_0006536","MONDO_0004979","EFO_0000341"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1626","canonicalSmiles":"CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1","inchiKey":"YNNUSGIPVFPVBX-NHCUHLMSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLEMASTINE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Clemastin","Clemastine","HS-592","NSC-756685"],"crossReferences":{"DailyMed":["clemastine%20fumarate"],"PubChem":["11111002","11112618","11114089","124882478","152146162"],"Wikipedia":["Clemastine"],"drugbank":["DB00283"],"chEBI":["3738"]},"childChemblIds":["CHEMBL1200795"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0007405","HP_0000989","EFO_0005531","MONDO_0005301","MONDO_0002406","MONDO_0005271","EFO_0003929","EFO_0005532","EFO_0007214","EFO_0003956"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 6 approved and 7 investigational indications."}
{"id":"CHEMBL165","canonicalSmiles":"Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1","inchiKey":"LUKBXSAWLPMMSZ-OWOJBTEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RESVERATROL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(e)-resveratrol","3,5,4'-Trihydroxy-trans-stilbene","BIA 6-512","BIA-6-512","Biofort","Ca 1201","Cuspidatin","Melinjo resveratrol 20","NSC-327430","Polygonin","Resveratrol","Resveratrol p 5","Resveratrol(e)-form","Resvida","Srt 501m","Trans-resveratrol"],"crossReferences":{"PubChem":["124883089","124883091","124883093","124883094","144203808","144208572","144213690","170466838","17388746","26747076","26747077","26751586","26751587","458391","49734167","50104223","50104224","50104225","50126366","85231343","855986","90341821"],"Wikipedia":["Resveratrol"],"drugbank":["DB02709"],"chEBI":["45713"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 36 investigational indications."}
{"id":"CHEMBL1682","canonicalSmiles":"OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"FBPFZTCFMRRESA-JGWLITMVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SORBITOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["7B5697N","D-glucitol","D-glucitol syrup","D-sorbitol","E 420","E-420(i)","E420","FEMA NO. 3029","Glucitol, d-","Ins no.420(i)","Ins-420(i)","Isomalt impurity, sorbitol-","NSC-25944","Neosorb p 60w","Sorbitol","Sorbitol (e420)","Sorbitol solutions"],"crossReferences":{"PubChem":["144213700","26757772","56322758"],"Wikipedia":["Sorbitol"],"drugbank":["DB01638"],"chEBI":["17924"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for constipation and has 7 investigational indications."}
{"id":"CHEMBL168276","canonicalSmiles":"O=[N+]([O-])c1cc(O)c(O)c([N+](=O)[O-])c1","inchiKey":"VDCDWNDTNSWDFJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3,5-DINITROCATECHOL (OR-486)","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,5-Dinitrocatechol"],"crossReferences":{"PubChem":["11111032","11113526","124879815","124879816","26747113","50104432","56463318","85230992","90341310"],"drugbank":["DB02105"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697737","canonicalSmiles":"CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl","inchiKey":"CHBRHODLKOZEPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOTIAZEPAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clozan"],"synonyms":["Clotiazepam"],"crossReferences":{"drugbank":["DB01559"]},"linkedTargets":{"rows":["ENSG00000182256","ENSG00000022355","ENSG00000011677","ENSG00000113327","ENSG00000163285","ENSG00000151834","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0005230"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for anxiety."}
{"id":"CHEMBL1697748","canonicalSmiles":"CC(=O)N[C@H]1[C@H](O[C@@H]2[C@@H](C(=O)O)O[C@@H](O[C@H]3[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]3NC(C)=O)[C@H](O)[C@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"KIUKXJAPPMFGSW-DNGZLQJQSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"HYALURONIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hyaluronic Acid","Hyaluronic acid"],"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1719","canonicalSmiles":"CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21.Cl","inchiKey":"HVRLZEKDTUEKQH-NOILCQHBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLOPATADINE HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1189432","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Olopatadine hydrochloride","Pataday","Pataday once daily relief","Pataday twice daily relief","Patanase","Patanol","Pazeo"],"synonyms":["ALO-4943A","ALO4943A","Allelock","KW-4679","KW4679","Olopatadine (as hydrochloride)","Olopatadine hcl","Olopatadine hydrochloride"],"crossReferences":{"DailyMed":["olopatadine%20hydrochloride"],"PubChem":["144205795","170465181","49681604"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","HP_0000989","EFO_0007141","EFO_1001417","EFO_0003956","EFO_0009450"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 4 approved indications."}
{"id":"CHEMBL173929","canonicalSmiles":"CC1=C[C@H](O)CC(C)(C)[C@H]1/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C","inchiKey":"KBPHJBAIARWVSC-RGZFRNHPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUTEIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["All-trans-lutein","All-trans-xanthophyll","Bo-xan","E 161","E 161b","E-161B","E-161B(I)","E161b","Floraglo","Floraglo lutein","INS NO.161B(I)","INS-161B(I)","Leutein","Lutein","Lutein a","Lutein from tagetes erecta","NSC-59193","Oro glo 7","Os 24","Trans-lutein","Vegetable lutein","Vegetable luteol","Xanthophyll","Xantofyl"],"crossReferences":{"PubChem":["144206147"],"Wikipedia":["Lutein"],"drugbank":["DB00137"],"chEBI":["28838"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1818341","canonicalSmiles":"CC(C)CNCc1ccc(-c2ccccc2S(=O)(=O)N2CCCC2)cc1","inchiKey":"OWVIKBRKPCTDEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04455242","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-04455242","Pf-04455242"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL188462","canonicalSmiles":"CN[C@@H](C)C/C=C/c1cncc(OC(C)C)c1","inchiKey":"RPCVIAXDAUMJJP-PZBABLGHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISPRONICLINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-3480","Azd3480","Ispronicline","TC-01734","TC-1734"],"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["EFO_0003888","MONDO_0005090","EFO_0001072","MONDO_0004975"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1909072","canonicalSmiles":"NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1","inchiKey":"OSJJYEUEJRVVOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPAMAZINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["Pipamazine"],"crossReferences":{"Wikipedia":["Pipamazine"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States."}
{"id":"CHEMBL193264","canonicalSmiles":"O=C(Nc1ccc2ccn(CCc3ccncc3)c2c1)c1cc(F)cc(N2CCOCC2)c1","inchiKey":"CPFBZMFUCGHBAP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL193264","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08730"],"chEBI":["46552"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL200238","canonicalSmiles":"O=C(O)c1ccc(-c2ccccc2Cl)o1","inchiKey":"PJGGWIHXGHQXMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL200238","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26514034","29215062","3711134"],"drugbank":["DB02909"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2046550","canonicalSmiles":"C/C(=C(/OCCOc1ccc(Cl)cc1)c1ccc(Cl)cc1Cl)n1ccnc1","inchiKey":"JMFOSJNGKJCTMJ-ZHZULCJRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMOCONAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Omoconazole"],"crossReferences":{"PubChem":["170465847"],"drugbank":["DB13684"]},"childChemblIds":["CHEMBL2107140"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2062154","canonicalSmiles":"C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2)C(=O)NC[C@H](NC(=O)CCC(=O)O)c1ccccc1","inchiKey":"FVQSSYMRZKLFDR-QRCSZXLUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CI-988","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ci-988","PD-134308"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2088033","canonicalSmiles":"CNC(=O)[C@@H](Cc1ccccc1F)CN1CCC2(CC1)OCCc1cc(F)sc12","inchiKey":"MZBCQWLYUQJXKA-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOP-1A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nop-1a"],"crossReferences":{"drugbank":["DB15208"]},"childChemblIds":["CHEMBL2204352"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2095223","canonicalSmiles":"CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=S(=O)(O)O","inchiKey":"OJPWHUOVKVKBQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROQUINE SULPHATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL76","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chloroquine sulfate","Chloroquine sulfate monohydrate","Chloroquine sulphate","Chloroquini sulfas","NSC-292296"],"crossReferences":{"chEBI":["50178"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2103822","canonicalSmiles":"CCC(=O)NC[C@@H]1C[C@H]1c1cccc2c1CCO2","inchiKey":"PTOIAAWZLUQTIO-GXFFZTMASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TASIMELTEON","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hetlioz","Hetlioz lq"],"synonyms":["BMS-214,778","BMS-214778","Tasimelteon","VEC-162"],"crossReferences":{"DailyMed":["tasimelteon"],"drugbank":["DB09071"],"chEBI":["79042"]},"linkedTargets":{"rows":["ENSG00000168412","ENSG00000134640"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","Orphanet_68335","MONDO_0002009","MONDO_0003406","EFO_0001421","Orphanet_819","MONDO_0024361","EFO_0004698"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved and 5 investigational indications."}
{"id":"CHEMBL2105708","canonicalSmiles":"Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12.Cl","inchiKey":"BWTNNZPNKQIADY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PONATINIB HYDROCHLORIDE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1171837","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iclusig"],"synonyms":["AP-24534 HCL","AP24534 HCL","Ponatinib hydrochloride"],"crossReferences":{"DailyMed":["ponatinib%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000097007","ENSG00000186716"],"count":2},"linkedDiseases":{"rows":["EFO_0000339","EFO_0000220","EFO_1000131","EFO_0000222","EFO_0008550","MONDO_0003541","EFO_0000311"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for acute lymphoblastic leukemia and chronic myelogenous leukemia and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105755","canonicalSmiles":"CC(C)(NC(=O)C1=C(O)[C@@H]2Oc3c(O)ccc4c3[C@@]23CCN(CC2CC2)[C@H](C4)[C@]3(O)C1)c1nc(-c2ccccc2)no1","inchiKey":"AXQACEQYCPKDMV-RZAWKFBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALDEMEDINE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Naldemedine","S-297995"],"crossReferences":{"DailyMed":["naldemedine%20tosylate"],"drugbank":["DB11691"]},"childChemblIds":["CHEMBL3039508"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["MONDO_0004880","EFO_0000278","EFO_0003843","HP_0002019","MONDO_0002203"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL2106085","canonicalSmiles":"O=C([O-])C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O.[K+]","inchiKey":"ULEUKTXFAJZAAV-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CLORAZEPATE MONOPOTASSIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1213252","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4311 CB","4311-CB","ABBOTT-39083","Clorazepate monopotassium","Clorazepate potassium","Potassium clorazepate"],"crossReferences":{"chEBI":["59591"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107313","canonicalSmiles":"CCN(CC)CCN1C(=O)c2c(c3c4cccc(Cl)c4n([C@@H]4O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]4O)c3c3[nH]c4c(Cl)cccc4c23)C1=O","inchiKey":"JSKFWUPVIZYJMR-UDOAKELVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BECATECARIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-181176","BMY-27557","Becatecarin","Deae-rebeccamycin","NSC-655649","XL-119","XL119 "],"crossReferences":{"drugbank":["DB06362"]},"linkedTargets":{"rows":["ENSG00000131747","ENSG00000198900","ENSG00000077097"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0003060","EFO_0006861","MONDO_0008170","MONDO_0008903","MONDO_0000956","EFO_0000702","EFO_0000574","MONDO_0002367","EFO_0000621","EFO_1001951"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL2107334","canonicalSmiles":"CC(C)(C)[N+]([O-])=Cc1ccc(S(=O)(=O)[O-])cc1S(=O)(=O)[O-].[Na+].[Na+]","inchiKey":"XLZOVRYBVCMCGL-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"DISUFENTON SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2111090","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,4-disulfonyl pnb","Cerovive","Disufenton sodium","Disufenton sodium salt","HPN-07","Hpn-07","NXY-059","OKN-007"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2107349","canonicalSmiles":"C[C@H](CN(C(=O)c1ccc(C#N)cc1)c1ccccn1)N1CCN(c2cccc3c2OCCO3)CC1.Cl","inchiKey":"GXYZREDEYDFJPT-ZMBIFBSDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LECOZOTAN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL372205","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lecozotan hcl","Lecozotan hydrochloride","SRA-333"],"linkedTargets":{"rows":["ENSG00000178394"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2107797","canonicalSmiles":"C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC","inchiKey":"WWYNJERNGUHSAO-CULCCENASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORGESTREL","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Opill","Ovrette"],"synonyms":["Dl-norgestrel","FH-122A","NSC-757251","Norgestrel","Prefest","Previfem","SH-70850","SH-850","Sprintec","Tri-Previfem","Tri-Sprintec","WY-3707"],"crossReferences":{"DailyMed":["norgestrel"],"PubChem":["144213928"]},"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["MP_0001914","MONDO_0011962"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and is indicated for hemorrhage and has 1 investigational indication."}
{"id":"CHEMBL2107822","canonicalSmiles":"Cc1ccc(-c2ncccn2)c(C(=O)N2C[C@H](COc3ccc(F)cn3)CC[C@H]2C)c1","inchiKey":"NPFDWHQSDBWQLH-QZTJIDSGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FILOREXANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Filorexant","MK-6096"],"crossReferences":{"drugbank":["DB12158"]},"linkedTargets":{"rows":["ENSG00000137252","ENSG00000121764"],"count":2},"linkedDiseases":{"rows":["EFO_1000783","MONDO_0002009","EFO_0004698"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2107874","drugType":"Antibody","blackBoxWarning":true,"name":"ROMOSOZUMAB","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Evenity"],"synonyms":["AMG 785","AMG-785","CDP-7851","CDP7851","Romosozumab","Romosozumab-aqqg"],"crossReferences":{"DailyMed":["romosozumab-aqqg"]},"linkedTargets":{"rows":["ENSG00000167941"],"count":1},"linkedDiseases":{"rows":["HP_0000938","EFO_0003931","EFO_0003854","EFO_0004260","Orphanet_666","EFO_0003882"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108308","drugType":"Protein","blackBoxWarning":false,"name":"TERTOMOTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GV-1001","GV1001","Gv1001","Tertomotide"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2108361","drugType":"Enzyme","blackBoxWarning":false,"name":"AMEDIPLASE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amediplase"],"description":"Enzyme drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108455","drugType":"Protein","blackBoxWarning":false,"name":"OCTOCOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Octocog alfa"],"crossReferences":{"DrugCentral":["5099"]},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108723","drugType":"Protein","blackBoxWarning":false,"name":"PEGINTERFERON LAMBDA-1A","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-914143","BMS914143","PEG-IL-29","PEG-RIL-29","PEG-RLL-29","Peginterferon lambda-1a","Pegylated interferon lambda"],"linkedTargets":{"rows":["ENSG00000185436","ENSG00000243646"],"count":2},"linkedDiseases":{"rows":["EFO_0000694","EFO_0004220","MONDO_0100096","EFO_0004197","EFO_0003047","EFO_0007304","EFO_0004239"],"count":7},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2108747","drugType":"Antibody","blackBoxWarning":false,"name":"TORALIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANTI-CD154","ANTI-CD40L","ANTI-GP39","E-6040","IDEC-131","Toralizumab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108964","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN, ISOPHANE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ins hum insulat","Ins hum protaphane","Ins humulin i","Ins hypurin bov isop","Ins hypurin pore isop","Ins innolet insulat","Ins insulat","Ins insulat novolet","Ins insuman basal","Ins insuman basal optiset","Ins insuman basal solostar","Ins novolet hum protaphane","Ins pork insulat","Ins pur-in hum isop","Nph iletin","Penfill"],"synonyms":["Insulin injection","Insulin, isophane","Isophane (aqueous suspension)","Isophane insulin"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109267","drugType":"Antibody","blackBoxWarning":false,"name":"M195","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["M195"],"linkedTargets":{"rows":["ENSG00000105383"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000565","EFO_0004251"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109526","drugType":"Antibody","blackBoxWarning":false,"name":"PG-110","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PG-110","Pg-110"],"linkedTargets":{"rows":["ENSG00000134259"],"count":1},"linkedDiseases":{"rows":["EFO_0004616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110857","canonicalSmiles":"Cn1nc(CO)nc1NCCCOc1cccc(CN2CCCCC2)c1","inchiKey":"VTLNPNNUIJHJQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAVOLTIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AH-23844 FREE BASE","Lavoltidine"],"crossReferences":{"drugbank":["DB12884"],"chEBI":["6550"]},"childChemblIds":["CHEMBL3989590"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2111090","canonicalSmiles":"CC(C)(C)[N+]([O-])=Cc1ccc(S(=O)(=O)O)cc1S(=O)(=O)O","inchiKey":"OVTCHWSLKGENKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DISUFENTON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL2107334"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL218427","canonicalSmiles":"Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@@H](N)CCC[N+](C)(C)C)CC5)CCOCC4)c3Cl)c2n1","inchiKey":"FQVSDHOWSLEEKJ-LJAQVGFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FASITIBANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fasitibant","Fasitibant cation","Fasitibant ion","MEN-16132","MEN-16132 FREE BASE"],"crossReferences":{"drugbank":["DB15646"]},"childChemblIds":["CHEMBL541758"],"linkedTargets":{"rows":["ENSG00000168398"],"count":1},"linkedDiseases":{"rows":["EFO_0004616","MONDO_0005178"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL220513","canonicalSmiles":"C[C@@H](C(=O)N1CCOCC1)N1CC[C@H](NS(=O)(=O)c2n[nH]c(-c3ccc(Cl)s3)n2)C1=O","inchiKey":"FKCQUVAGEOSYRU-QWRGUYRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL220513","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07804"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL221326","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"NMLMACJWHPHKGR-NCOIDOBVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIQUAFOSOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diquafosol","INS-365"],"crossReferences":{"Wikipedia":["Diquafosol"],"chEBI":["27791"]},"childChemblIds":["CHEMBL1767408"],"linkedTargets":{"rows":["ENSG00000186912","ENSG00000169860","ENSG00000175591","ENSG00000171631"],"count":4},"linkedDiseases":{"rows":["EFO_1000906"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL227381","canonicalSmiles":"O=S(=O)(NCCNCCOCc1ccc(Cl)cc1)c1cccc2cnccc12","inchiKey":"AUHWQSZMVMMRLM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL227381","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07947"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2361014","canonicalSmiles":"CC(=O)OC1(c2ccccc2)CCN(CCc2ccccc2)CC1","inchiKey":"BVURVTVDNWSNFN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2361014","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206386"],"drugbank":["DB01562"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL24441","canonicalSmiles":"CNCCc1ccccn1","inchiKey":"UUQMNUMQCIQDMZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAHISTINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Betahistine"],"crossReferences":{"Wikipedia":["Betahistine"],"drugbank":["DB06698"],"chEBI":["35677"]},"childChemblIds":["CHEMBL4303472","CHEMBL1451277","CHEMBL1446813","CHEMBL1464589"],"linkedTargets":{"rows":["ENSG00000101180","ENSG00000196639"],"count":2},"linkedDiseases":{"rows":["EFO_0003888","EFO_0006862","EFO_0004566","HP_0003124","MONDO_0002009","HP_0002321","EFO_0001073"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for vertigo and has 6 investigational indications."}
{"id":"CHEMBL281948","canonicalSmiles":"COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4","inchiKey":"KOZFSFOOLUUIGY-SOLYNIJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"K-252A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["K-252A"],"crossReferences":{"Wikipedia":["K252a"],"drugbank":["DB02152"],"chEBI":["43616"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL294951","canonicalSmiles":"CN1CCC(=C2c3ccccc3CCc3sccc32)CC1","inchiKey":"FIADGNVRKBPQEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIZOTYLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sandomigran"],"synonyms":["BC-105","Pizotifen","Pizotyline"],"crossReferences":{"PubChem":["124892409","144205577","170466311","26756535"],"Wikipedia":["Pizotifen"],"drugbank":["DB06153"],"chEBI":["50212"]},"childChemblIds":["CHEMBL1592663","CHEMBL1707025","CHEMBL1512796","CHEMBL1326119"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3140370","canonicalSmiles":"CN1CCN(CCCCN2C(=O)CN(/N=C/c3ccc(-c4ccc(Cl)cc4)o3)C2=O)CC1.Cl.Cl","inchiKey":"HHPSICLSNHCSNZ-BYEGLACWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZIMILIDE DIHYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL123558","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azimilide dihydrochloride","Azimilide hydrochloride","NE-10064"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3183409","canonicalSmiles":"CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F","inchiKey":"HJBWBFZLDZWPHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APALUTAMIDE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Erleada"],"synonyms":["ARN-509","Apalutamide","Arn-509","JNJ-56021927"],"crossReferences":{"DailyMed":["apalutamide"],"PubChem":["174007290"],"drugbank":["DB11901"]},"childChemblIds":["CHEMBL4082191","CHEMBL4105484","CHEMBL4100200","CHEMBL4062002"],"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0003826","EFO_0000616","EFO_0001421","EFO_0000196","EFO_0000673","MONDO_0008315","EFO_0001663","EFO_0000311"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 5 approved and 2 investigational indications."}
{"id":"CHEMBL3183549","canonicalSmiles":"CC(=C(CCOP(=O)(O)O)SC(=O)c1ccccc1)N(C=O)Cc1cnc(C)nc1N","inchiKey":"BTNNPSLJPBRMLZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENFOTIAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["8088 C.B","8088 C.B.","8088-CB","8088CB","Benfothiamine","Benfotiamine","Benphothiamine","Benzoylthiamine monophosphate","Benzoylthiamine o-monophosphate","Benzoylthiaminmonophosphat","Biotamin","NSC-758241","S-benzoylthiamine monophosphate"],"crossReferences":{"PubChem":["144204148","170465987"],"chEBI":["41039"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3185958","canonicalSmiles":"CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"PYTMYKVIJXPNBD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOMIPHENE CITRATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2355051","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clomid","Clomiphene citrate","Clophene","Milophene","Serophene"],"synonyms":["Chloramiphene","Clomid","Clomifene citrate","Clomifeni citras","Clomiphene citrate","Clomiphene citrate (1:1)","Clostilbegyt","Ikaclomine","MER-41","MRL-41","NSC-35770","Pergotime"],"crossReferences":{"DailyMed":["clomiphene%20citrate"],"PubChem":["144212192"],"chEBI":["3753"]},"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MP_0001914","EFO_0000545","EFO_0008560","MONDO_0002775","EFO_0000660"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL325023","canonicalSmiles":"Cc1nc(C)c(-c2[nH]nc3c2C(=O)c2c(NC(=O)NN4CCN(C)CC4)cccc2-3)s1","inchiKey":"KRKQVGZXTNLQSV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL325023","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07622"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3304484","canonicalSmiles":"CCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC.CCCCCCCC(=O)OCC(O)CO.CCCCCCCCCC(=O)OCC(O)CO","inchiKey":"JFUMHQVCWWFATH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MONOCTANOIN","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3301678"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL3544909","canonicalSmiles":"C=C1CC[C@H](O)C/C1=C/C=C1\\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)(C)O.O","inchiKey":"WRLFSJXJGJBFJQ-WPUCQFJDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIFEDIOL","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1040","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calderol","Rayaldee"],"synonyms":["CTAP101","Calcidiol","Calcifediol","Calcifediol hydrate","Ctap-101","Didrogyl","Hidroferol","Rayaldy","U-32,070E","U-32070E"],"crossReferences":{"DailyMed":["calcifediol"]},"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_1001173","MONDO_0100096","HP_0002024","HP_0001919","EFO_0003884","EFO_0003762","MONDO_0004979","EFO_0000612","EFO_0003918","EFO_0005754"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and has 3 approved and 5 investigational indications."}
{"id":"CHEMBL3545208","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD3161","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd3161"],"linkedTargets":{"rows":["ENSG00000169432"],"count":1},"linkedDiseases":{"rows":["EFO_0005762"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545221","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD2423","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd2423"],"linkedTargets":{"rows":["ENSG00000121807"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","EFO_0000341","EFO_0003843"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL357452","canonicalSmiles":"O=C1OCc2c(Cl)c(Cl)c(Cl)c(Cl)c21","inchiKey":"NMWKWBPNKPGATC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4,5,6,7-TETRACHLOROPHTHALIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03302"],"chEBI":["47617"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL370252","canonicalSmiles":"CC1CCc2cc(F)cc3c(=O)c(C(=O)O)cn1c23","inchiKey":"DPSPPJIUMHPXMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUMEQUINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apurone","Flumequine","NSC-757806"],"crossReferences":{"PubChem":["104171372","144204391","170466145","26747215","56423139","856003"],"drugbank":["DB08972"],"chEBI":["85269"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL371064","canonicalSmiles":"CCCN1CCN(c2ccc(C(=O)NC3(C(=O)NCC#N)CCCCC3)cc2)CC1","inchiKey":"LLCRBOWRJOUJAE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BALICATIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AAE-581","AAE581","Balicatib"],"crossReferences":{"drugbank":["DB12239"]},"linkedTargets":{"rows":["ENSG00000143387"],"count":1},"linkedDiseases":{"rows":["EFO_0003882","MONDO_0005178"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL372303","canonicalSmiles":"CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1","inchiKey":"UYJZZVDLGDDTCL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PJ34","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08348"]},"childChemblIds":["CHEMBL3233481","CHEMBL4161122"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL379642","canonicalSmiles":"O=C(Sc1nnc(C(F)(F)F)[nH]1)c1ccc(C#Cc2ccccc2)o1","inchiKey":"VNGWUVBXUIDQTK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL379642","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07743"],"chEBI":["42403"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL381806","canonicalSmiles":"NC(=O)[C@@H]1Cc2ccccc2CN1C(=O)C[C@H](N)Cc1ccccc1F","inchiKey":"OEVYDSSAPNIURZ-AEFFLSMTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL381806","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04578"],"chEBI":["39484"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL382311","canonicalSmiles":"CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc([C@@H]2CC(=O)NS2(=O)=O)cc1)C(N)=O","inchiKey":"UILYPHAKDBTKQV-UFYCRDLUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL382311","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08003"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833377","canonicalSmiles":"O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Zn+2]","inchiKey":"WHMDKBIGKVEYHS-IYEMJOQQSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ZINC GLUCONATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bis(d-gluconato-o1,o2) zinc","Gluconic acid zinc complex","Zinc d-gluconate (1:2)","Zinc gluconate","Zincum gluconicum"],"crossReferences":{"DrugCentral":["4343"],"drugbank":["DB11248"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3989519","canonicalSmiles":"CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O.Cl.O","inchiKey":"ZOMBFZRWMLIDPX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXAPRAM HYDROCHLORIDE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1754","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dopram","Doxapram hydrochloride","Stimulexin"],"synonyms":["AHR-619","Doxapram hcl","Doxapram hydrochloride","Doxapram hydrochloride hydrate","Doxapram hydrochloride monohydrate","NSC-170958","NSC-760347","Stimulexin"],"crossReferences":{"DailyMed":["doxapram%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000169427","ENSG00000171303"],"count":2},"linkedDiseases":{"rows":["EFO_0009444","EFO_0004262","EFO_0003917","EFO_0003818","HP_0002104"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and is indicated for lung disease and has 1 investigational indication."}
{"id":"CHEMBL3989921","canonicalSmiles":"CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C.O=C(O)/C=C\\C(=O)O","inchiKey":"VXZCUHNJXSIJIM-MEBGWEOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NERATINIB MALEATE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL180022","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nerlynx"],"synonyms":["Neratinib maleate"],"crossReferences":{"DailyMed":["neratinib%20maleate"]},"linkedTargets":{"rows":["ENSG00000146648","ENSG00000178568","ENSG00000141736"],"count":3},"linkedDiseases":{"rows":["MONDO_0007254","EFO_0000305"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for breast cancer and breast carcinoma."}
{"id":"CHEMBL3989970","canonicalSmiles":"C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3OC)c3ncn(C)c3n2)C[C@H]1F","inchiKey":"JYIUNVOCEFIUIU-GHMZBOCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAVELERTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Egfr t790m inhibitor pf-06747775","Mavelertinib","PF-06747775"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0003060"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3990039","drugType":"Antibody","blackBoxWarning":false,"name":"MARSTACIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Marstacimab","PF-06741086"],"linkedTargets":{"rows":["ENSG00000003436"],"count":1},"linkedDiseases":{"rows":["Orphanet_448","Orphanet_98879","Orphanet_98878"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3990694","canonicalSmiles":"C1CNCCN1.C1CNCCN1.C1CNCCN1.O=C(O)CC(O)(CC(=O)O)C(=O)O.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"JDDHUROHDHPVIO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERAZINE CITRATE","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antepar","Bryrel","Multifuge","Piperazine citrate","Vermidol"],"synonyms":["Piperazine citrate"],"childChemblIds":["CHEMBL3989678"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1954."}
{"id":"CHEMBL4061538","canonicalSmiles":"Cl.Cl.N[C@@H](Cc1ccc([N+]([O-])(CCCl)CCCl)cc1)C(=O)O","inchiKey":"GIGCDIVNDFQKRA-LTCKWSDVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4061538","maximumClinicalTrialPhase":0,"parentId":"CHEMBL4117516","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06082"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297404","canonicalSmiles":"COc1ccc(CC2OC(=O)NC2=O)cc1C(=O)NCc1ccc(C(F)(F)F)cc1","inchiKey":"ORZMUVMQJPGFOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0767","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK 0767","Mk-0767","Mk0767"],"crossReferences":{"drugbank":["DB12055"]},"linkedTargets":{"rows":["ENSG00000186951","ENSG00000132170"],"count":2},"linkedDiseases":{"rows":["EFO_0000195","MONDO_0005148","EFO_0000400"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297408","canonicalSmiles":"CC[C@@H]1SC2(CCN(C)CC2)NC1=O","inchiKey":"PHOZOHFUXHPOCK-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NGX-267","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AF-267B","NGX267","Ngx-267","Ngx267"],"crossReferences":{"drugbank":["DB05152"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4297463","canonicalSmiles":"COc1cc(C)[nH]c(=O)c1CNC(=O)c1c(C)n([C@H](C)C2CCN(CC(F)(F)F)CC2)c2ccccc12","inchiKey":"HPODOLXTMDHLLC-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CPI-1205","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CPI-1205","Cpi-1205","Ezh2 inhibitor cpi-1205","Lirametostat"],"crossReferences":{"drugbank":["DB14581"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297479","canonicalSmiles":"C[C@@H](O)c1nnc([C@H]2C[C@H](NC(=O)c3cc(-c4ccccc4)no3)C2)o1","inchiKey":"XPEHHUISIBFLHX-RAIGVLPGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NESOLICAFTOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nesolicaftor","Nesolicitor","PTI-428","Pti-428"],"crossReferences":{"drugbank":["DB15239"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297847","drugType":"Unknown","blackBoxWarning":false,"name":"VGX-100","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vgx-100"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297974","drugType":"Protein","blackBoxWarning":false,"name":"CALCITONIN EEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcitonin eel","Eel calcitonin","HC-58","Hc-58"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297992","drugType":"Unknown","blackBoxWarning":false,"name":"IMGN-779","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMGN-779","IMGN779","Imgn-779","Imgn779"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298079","drugType":"Unknown","blackBoxWarning":false,"name":"SEPHB4-HSA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Recombinant ephb4-hsa fusion protein","Sephb4-hsa"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4298207","drugType":"Protein","blackBoxWarning":false,"name":"ZILUCOPLAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RA101495","Zilucoplan"],"linkedTargets":{"rows":["ENSG00000106804"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","EFO_0004991","MONDO_0004976","Orphanet_447"],"count":4},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL430639","canonicalSmiles":"Cc1cccc([C@]23SCCN2C(=O)c2ccccc23)c1","inchiKey":"FQVDJZWFSZSGGA-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL430639","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07472"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL442720","canonicalSmiles":"CS(=O)(=O)CC[C@H](N)C(=O)O","inchiKey":"UCUNFLYVYCGDHP-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHIONINE SULFONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-Methionine Sulfone"],"crossReferences":{"drugbank":["DB03790"],"chEBI":["21363"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL445001","canonicalSmiles":"C[C@@H]([C@H](O)c1ccccc1)N(C)C","inchiKey":"FMCGSUUBYTWNDP-ONGXEEELSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL445001","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205074"],"drugbank":["DB11278"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL450613","canonicalSmiles":"C[C@H]1CCC[C@H](O)CCCCCc2cc(O)cc(O)c2C(=O)O1","inchiKey":"DWTTZBARDOXEAM-GXTWGEPZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZERANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ralabol","Ralgro"],"synonyms":["(-)-.alpha.-zearalanol","MK-188","P-1496","THFES (HM)","Zeranol"],"crossReferences":{"PubChem":["144204524","144208401","17389521","3715954","49674197"],"drugbank":["DB11478"],"chEBI":["35064"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594284","drugType":"Small molecule","blackBoxWarning":false,"name":"PADELIPORFIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tookad"],"synonyms":["Padeliporfin","WST-11","WST11","Wst11"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and has 5 investigational indications."}
{"id":"CHEMBL4594327","drugType":"Antibody","blackBoxWarning":false,"name":"BENTRACIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bentracimab","MEDI-2452","MEDI2452","PB-2452","PB2452"],"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594351","canonicalSmiles":"Cc1c(Cc2ccc(-n3cccn3)cc2)cc2c(c1F)CN([C@H]1COCC[C@@H]1O)C2=O","inchiKey":"WFSARWQASFQZMG-VXKWHMMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-071","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tak-071"],"linkedTargets":{"rows":["ENSG00000168539"],"count":1},"linkedDiseases":{"rows":["MONDO_0005180","MONDO_0004975"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594388","drugType":"Antibody","blackBoxWarning":false,"name":"ANSUVIMAB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ebanga"],"synonyms":["Ansuvimab","Ansuvimab-zykl","EVB-114","EVB114","EboV mAb114","MAB-114","MAB114","Mab114","VRC-EBOMAB092-00-AB"],"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for ebola hemorrhagic fever and infection."}
{"id":"CHEMBL460741","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](CO)[C@@H](OP(=O)(O)O)[C@H]2O)c(=O)[nH]1","inchiKey":"FOGRQMPFHUHIGU-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Uridine 3'-Phosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Uridine 3'-Phosphate"],"crossReferences":{"drugbank":["DB02714"],"chEBI":["28895"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4650343","canonicalSmiles":"Cc1cc(Nc2cc3ncccc3c(N[C@H]3C[C@@H]4CC[C@H](C3)N4CCC#N)n2)n[nH]1","inchiKey":"DADAEARVGOQWHV-OSYLJGHBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IZENCITINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Izencitinib","TD-1473","TD1473","Td-1473"],"linkedTargets":{"rows":["ENSG00000096968","ENSG00000162434","ENSG00000105639","ENSG00000105397"],"count":4},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000384","EFO_0003767"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4650512","drugType":"Unknown","blackBoxWarning":false,"name":"RO-7296682","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RG-6292","RG6292","RO-7296682","RO7296682","Ro-7296682","Ro7296682"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650519","drugType":"Antibody","blackBoxWarning":false,"name":"ULILEDLIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TJ-004309","TJ-D5","TJ004309","Tj004309","Uliledlimab"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL471638","canonicalSmiles":"CCCC(CCC)C(=O)NCC(N)=O","inchiKey":"RALGCAOVRLYSMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALROCEMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TV-1901","Valrocemide"],"crossReferences":{"drugbank":["DB06657"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4802134","canonicalSmiles":"N#CCNC(=O)CNc1ccc(C(=O)O)cc1","inchiKey":"ILTWRLHXJMWZHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"H-100","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["H-100"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4802219","drugType":"Unknown","blackBoxWarning":false,"name":"TAS-266","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TAS-266","TAS266","Tas-266","Tas266"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL498416","canonicalSmiles":"Nc1ccccc1C(=O)C[C@H](N)C(=O)O","inchiKey":"YGPSJZOEDVAXAB-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-KYNURENINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-kynurenine"],"crossReferences":{"PubChem":["26756700"],"Wikipedia":["Kynurenine"],"drugbank":["DB02070"],"chEBI":["16946"]},"childChemblIds":["CHEMBL1732584"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL501515","canonicalSmiles":"CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C","inchiKey":"GZYPWOGIYAIIPV-JBDTYSNRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GINSENOSIDE RB1","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ginsenoside Rb1"],"crossReferences":{"drugbank":["DB06749"],"chEBI":["67989"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL507048","canonicalSmiles":"CCC(C)CCCCC(=O)NCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H]([C@@H](C)O)NC1=O","inchiKey":"RPABDKTXMKOGKI-OYTUFZPASA-N","drugType":"Protein","blackBoxWarning":false,"name":"COLIMYCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Colimycin","Colistimethate sodium","Colistin sodium methanesulfonate","NSC-756688","W 1929","W-1929"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL52939","canonicalSmiles":"COc1cccc(CCc2ccccc2OCC(CN(C)C)OC(=O)CCC(=O)O)c1","inchiKey":"FFYNAVGJSYHHFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARPOGRELATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sarpogrelate","Sarpogrelate hydrochloride"],"crossReferences":{"PubChem":["124893325","174006666","50112742"],"drugbank":["DB12163"]},"childChemblIds":["CHEMBL541829"],"linkedTargets":{"rows":["ENSG00000102468"],"count":1},"linkedDiseases":{"rows":["EFO_0001645","EFO_0000401","EFO_0003884","MONDO_0002679","EFO_0000319","EFO_0004265"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL554496","canonicalSmiles":"CCOc1ccc(-c2c(C#N)c(N)nc3sc(C(N)=O)c(N)c23)cc1","inchiKey":"UOPQHPBCVYHSFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL554496","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08788"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL605525","canonicalSmiles":"C=C1[C@H](O)CC(=C/C=C2\\CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@@H](C)CCCC(C)(C)O)C[C@H]1O","inchiKey":"UHMPCVGLSKFXHR-NAQZCRMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DP001","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2MD","Dp001"],"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_1001173","EFO_0003854","EFO_0003882"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL62193","canonicalSmiles":"COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1","inchiKey":"ZZORFUFYDOWNEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFADIMETHOXINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Madribon"],"synonyms":["NSC-683544","NSC-757860","Sulfadimethoxine","Sulphadimethoxine"],"crossReferences":{"PubChem":["11112268","144203956","170465690","26747078","56424126","855993"],"Wikipedia":["Sulfadimethoxine"],"drugbank":["DB06150"],"chEBI":["32161"]},"childChemblIds":["CHEMBL2107253"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease. It was withdrawn in United States."}
{"id":"CHEMBL682","canonicalSmiles":"CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O","inchiKey":"OVCDSSHSILBFBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMODIAQUINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amodiaquin","Amodiaquine","Amodiaquinum","GNF-Pf-5648","NSC-13453","SJ000110703","Sunoquine"],"crossReferences":{"PubChem":["50085969"],"Wikipedia":["Amodiaquine"],"drugbank":["DB00613"],"chEBI":["2674"]},"childChemblIds":["CHEMBL1357648","CHEMBL1630","CHEMBL3137745","CHEMBL1707005","CHEMBL3216010"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for malaria and has 5 investigational indications."}
{"id":"CHEMBL6966","canonicalSmiles":"COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC","inchiKey":"SGTNSNPWRIOYBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERAPAMIL","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CP-16,533-1","CP-16533-1","CP-165331","Calan","Covera-HS","D-365","Iproveratril","Isoptin","NSC-272306NA","Tarka","Verapamil","Verapamil slow release","Verelan"],"crossReferences":{"DailyMed":["verapamil%20hydrochloride"],"PubChem":["104171262","124881789","124881790","124881792","124881795","144203851","170464904","174316170","26751825","50104518","50104519","50104520","90340771"],"Wikipedia":["Verapamil"],"drugbank":["DB00661"],"chEBI":["77733"]},"childChemblIds":["CHEMBL1280","CHEMBL1707604","CHEMBL483787"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_0003777","EFO_0000275","HP_0004763","EFO_1001413","EFO_1000994","EFO_0000289","EFO_0003144","EFO_0004253","EFO_0004616","EFO_0004212","EFO_0000183","EFO_0000400","EFO_0000407","HP_0000360","HP_0002140","EFO_0004269","EFO_0000319","Orphanet_558","EFO_0003843","EFO_0000384","EFO_0000537","MP_0001914","EFO_0003890","Orphanet_33069","MONDO_0100096","MONDO_0005147","HP_0004308","EFO_0008583","MONDO_0005148"],"count":29},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 4 approved and 17 investigational indications."}
{"id":"CHEMBL703","canonicalSmiles":"C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C","inchiKey":"AXOIZCJOOAYSMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SUXAMETHONIUM","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Anectine","Quelicin","Succinylcholine","Succinylcholine cation","Succinylcholine ion","Sucostrin","Suxamethonium","Suxamethonium cation","Suxamethonium ion"],"crossReferences":{"DailyMed":["succinylcholine%20chloride"],"PubChem":["11111825","90341285"],"drugbank":["DB00202"],"chEBI":["45652"]},"childChemblIds":["CHEMBL2104486","CHEMBL3391771","CHEMBL983"],"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["HP_0003326","MONDO_0002050","HP_0001662","EFO_0005323","EFO_0000712","EFO_0002950"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL826","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21","inchiKey":"IDYZIJYBMGIQMJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENOXACIN","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Comprecin","Flumark","Penetrex"],"synonyms":["AT-2266","CI-919","Enoxacin","NSC-629661","NSC-758416","PD 107779","PD-107779"],"crossReferences":{"PubChem":["11112842","124882681","144204239","160657818","170465263","174006234","494643","855964"],"Wikipedia":["Enoxacin"],"drugbank":["DB00467"],"chEBI":["157175"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for bacterial disease and has 2 investigational indications."}
{"id":"CHEMBL8706","canonicalSmiles":"C#CCN(C)CCCOc1ccc(Cl)cc1Cl","inchiKey":"BTFHLQRNAMSNLC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLORGILINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clorgiline","Clorgyline","M&B 9302","clorgyline"],"crossReferences":{"PubChem":["11111452","11111453","90341614"],"Wikipedia":["Clorgiline"],"drugbank":["DB04017"],"chEBI":["3763"]},"childChemblIds":["CHEMBL539507"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL87708","canonicalSmiles":"CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1","inchiKey":"SAPNXPWPAUFAJU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOFEPRAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lofepramine"],"crossReferences":{"PubChem":["50111779","50111780"],"Wikipedia":["Lofepramine"],"drugbank":["DB13411"],"chEBI":["47782"]},"childChemblIds":["CHEMBL2106638"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for unipolar depression."}
{"id":"CHEMBL89705","canonicalSmiles":"Cn1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)c4ccc(N(CCCl)CCCl)cc4)cn3C)cn2C)cc1C(=O)NCCC(=N)N","inchiKey":"ARKYUICTMUZVEW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALLIMUSTINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tallimustine"],"crossReferences":{"drugbank":["DB15466"]},"childChemblIds":["CHEMBL545612"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL902","canonicalSmiles":"NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1","inchiKey":"XUFQPHANEAPEMJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FAMOTIDINE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Famotidine","Famotidine preservative free","Famotidine preservative free (pharmacy bulk)","Fluxid","Pepcid","Pepcid ac","Pepcid preservative free","Pepcid rpd"],"synonyms":["Amfamox","Fadul","Famodil","Famosan","Famotidine","Famoxal","Ganor","Gastridin","Gastropen","L 643341","Lecedil","MK-208","Motiax","Muclox","NSC-757810","Pepcidac","Pepdine","Pepdul","YM-11170"],"crossReferences":{"DailyMed":["famotidine"],"PubChem":["11111194","11111195","144203704","144212144","170464877","26748463","26753575","49681730","50106279","85231052","855518"],"TG-GATEs":["85"],"Wikipedia":["Famotidine"],"drugbank":["DB00927"],"chEBI":["4975"]},"linkedTargets":{"rows":["ENSG00000113749"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","HP_0002239","EFO_0004280","Orphanet_232","EFO_0000756","MONDO_0043839","MONDO_0020657","EFO_1001951","EFO_0003948","MONDO_0001056","HP_0004398","EFO_0006890","MONDO_0017287","EFO_0000676","EFO_0000641","HP_0100749","EFO_0000616","EFO_0000685","MONDO_0004658","MONDO_0004670","EFO_0000180","EFO_0004607","EFO_0003060","EFO_0002609","EFO_0000311","EFO_0008533","EFO_0004232","EFO_0009454","MONDO_0100096","EFO_0000764","EFO_0005611","MONDO_0005178","HP_0100633","EFO_0009878"],"count":34},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 9 approved and 19 investigational indications."}
